Seroprevalence and associated factors of Hepatitis B virus infection among pregnant women attending Antenatal care clinic in public hospitals in the Central Ethiopia region: A cross-sectional study

埃塞俄比亚中部地区公立医院产前保健门诊孕妇乙型肝炎病毒感染血清阳性率及相关因素:一项横断面研究

阅读:1

Abstract

Hepatitis B virus infection poses a significant public health challenge among pregnant women in sub-Saharan Africa, including Ethiopia, where it is often underdiagnosed and underreported. This study aimed to determine the seroprevalence and associated factors of hepatitis B virus infection among pregnant women attending antenatal care in public hospitals in the Central Ethiopian region. A hospital-based cross-sectional study was conducted from October 1, 2023, to March 1, 2024, among 482 pregnant women selected using systematic random sampling. Blood samples were collected and tested for hepatitis B surface antigen, and data were gathered using a structured, interviewer-administered questionnaire. Data were entered into Epi Data version 3.1 and analyzed using SPSS version 26. Logistic regression analysis identified factors associated with hepatitis B infection, with significance at p < 0.05. The response rate was 98.8%. Most participants (66.2%) were aged 18-28 years, with a mean age of 28. The overall seroprevalence of hepatitis B virus infection was 12.8% (95% CI: 10.1, 16.2). A maternal educational level of diploma and above (AOR: 0.23; 95% CI: 0.09, 0.62) and no history of hospital admission (AOR: 0.23; 95% CI: 0.10, 0.53) were linked to a lower risk. In contrast, being unable to read and write (AOR: 2.67; 95% CI: 1.14, 6.26), having a medium (4-6) or large (≥7) family size (AOR: 2.34; 95% CI: 1.15, 4.78) and (AOR: 3.65; 95% CI: 1.33, 10.04), respectively, history of traditional delivery care (AOR: 2.46; 95% CI: 1.04, 5.84), and history of abortion (AOR: 2.90; 95% CI: 1.37, 6.11) were associated with higher risk. Hepatitis B virus infection remains highly prevalent among pregnant women in the study area. Strengthening family-centered healthcare, improving screening and vaccination coverage, and enhancing community-based awareness and prevention initiatives are essential to reduce the burden of infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。